Zika virus infection – United States of America - United States Virgin Islands
On 25 January 2016, the National IHR Focal Point for the United States of America notified PAHO/WHO of the first laboratory-confirmed cases of Zika virus infection in St. Croix, one of the three main islands in the United States Virgin Islands (USVI). The USVI Department of Health received laboratory confirmation of the case on 22 January. The patient is a non-pregnant woman from USVI who reported the onset of fever, rash, conjunctivitis and arthralgia on 1 January. She had not travelled in the three weeks that preceded the onset of symptoms. A serum sample obtained from the patient on 8 January tested IgM positive at th...
Source: WHO Disease Outbreaks - January 29, 2016 Category: Infectious Diseases Tags: pesticide [subject], insecticides, fungicides, risk factor [subject], risk, health risks, water [subject], safe water, wastewater, greywater, clean water, Disease outbreak news [doctype], Region of the Americas [region], United States of America [country] Source Type: news
U.S. Scientists Are Starting From Ground Zero With The Zika Vaccine
As the research community gears up to address Zika virus, one common question has been why, if we’ve known about Zika since 1947, are we only starting these efforts in 2016? As Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, admitted, the disease is uncharted territory. "We, prior to this time, have really not spent anything on Zika,” he said during a press conference Thursday. Currently, there is no cure and no vaccine for the disease, and diagnosing the disease takes up to two weeks in specialized labs. To ramp up research on the Zika virus threat, the...
Source: Healthy Living - The Huffington Post - January 29, 2016 Category: Consumer Health News Source Type: news
Zika virus infection – Dominican Republic
On 23 January 2016, the National IHR Focal Point for the Dominican Republic notified PAHO/WHO of 10 laboratory-confirmed cases of Zika virus infection. Of the 10 cases, 8 are locally-acquired and 2 imported from El Salvador. The cases are from Distrito Nacional, and the municipalities of Santo Domingo Norte, Jimani-Independencia and Santa Cruz-Barahona. While 8 of the 10 cases are aged 15 to 57 years old, the remaining 2 cases are children under five years old. Onset of symptoms ranges from 3 to 18 January. All cases presented fever and rash; 8 of the 10 cases had conjunctivitis, 6 of the 10 cases experienced malaises, h...
Source: WHO Disease Outbreaks - January 27, 2016 Category: Infectious Diseases Tags: pesticide [subject], insecticides, fungicides, risk factor [subject], risk, health risks, water [subject], safe water, wastewater, greywater, clean water, Disease outbreak news [doctype], Dominican Republic [country], Region of the Americas [region] Source Type: news
Zika virus: your questions answered
"Three Britons have contracted Zika virus – which may cause severe birth defects – after travelling to South and Central America," BBC News reports. So what is the Zika virus and what steps can you take to protect yourself? Answers below.
What is the Zika virus?
The Zika virus is a mosquito-borne infection, which isn't harmful in most cases. However, it may be harmful for pregnancies, as it's been linked to birth defects – specifically, abnormally small heads (microcephaly).
It was first detected in the Zika forest of Uganda in 1947, but is now thought to have spread through most of South and Centra...
Source: NHS News Feed - January 25, 2016 Category: Consumer Health News Tags: Medical practice Pregnancy/child QA articles Source Type: news
At What Age Does the Risk of Infant Listeria Infection Decrease?
Discussion
Neonatal bacterial infections are commonly caused by Group B Streptococcus, enteric gram-negative organisms such as Escherichia coli, coagulase negative Staphylococcus, Listeria monocytogenes and Haemophilus influenza. Infections are usually because of transplacental infection or ascending infection from the mother’s genitourinary tract. Empiric treatment for suspected sepsis for neonates is usually combined IV aminoglycoside and expanded-spectrum penicillin antibiotic therapy in the US and Canada and this combination specifically covers for Listeria.
Listeria monocytogenes was first discovered in 1927 ...
Source: PediatricEducation.org - January 25, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Eleven Bio's eye drug fails another late-stage study
(Reuters) - Eleven Biotherapeutics Inc said its lead eye drug failed in a late-stage trial in treating patients with severe allergic conjunctivitis, sending its shares down 36 percent in after-market trading. (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
Ocular Therapeutix Dextenza NDA accepted by FDA
Ocular Therapeutix (NSDQ:OCUL) said today the FDA accepted the new drug application for its drug-device combo Dextenza for treating ocular pain following ophthalmic surgery.
Bedford, Mass.-based Ocular Therapeutix’s Dextenza, formerly known as OTX-DP, is designed to deliver sustained dosage of dexamethasone over 4 weeks using a hydrogel plug inserted into a tear duct. The plug then dissolves and is flushed from the body as tears.
“We are pleased that Ocular Therapeutix’s first NDA filing with our lead product candidate, Dextenza, has been officially accepted for review by the FDA. This is an important miles...
Source: Mass Device - December 9, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Optical/Ophthalmic Food & Drug Administration (FDA) Regulatory/Compliance Ocular Therapeutix Source Type: news
MassDevice.com +3 | The top 3 medtech stories for November 24, 2015
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Ocular Therapeutix launches another pivotal for Dextenza eye drug-device combo
Ocular Therapeutix said today that it launched another pivotal trial for its Dextenza drug-device combination, its 2nd study of the treatment for an allergic conjunctivitis indication.
Bedford, Mass.-based Ocular Th...
Source: Mass Device - November 24, 2015 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news
Ocular Therapeutix launches another pivotal for Dextenza eye drug-device combo
Ocular Therapeutix (NSDQ:OCUL) said today that it launched another pivotal trial for its Dextenza drug-device combination, its 2nd study of the treatment for an allergic conjunctivitis indication.
Bedford, Mass.-based Ocular Therapeutix has had mixed results with Dextenza, formerly known as OTX-DP, which is designed to deliver sustained dosage of dexamethasone over 4 weeks, using a hydrogel plug inserted into a tear duct. The plug then dissolves and is flushed from the body as tears.
In March, Ocular said a 1st, 247-patient trial examining Dextenza for reducing pain and inflammation after cataract surgery showed that 3...
Source: Mass Device - November 24, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Drug-Device Combinations Optical/Ophthalmic Ocular Therapeutix Source Type: news
Inflamax Research Announces Today the Commencement of a Phase IIa...
Inflamax Research Announces Today the Commencement of a Phase IIa Allergic Conjunctivitis Trial Testing a Novel Aldehyde Trap from Aldeyra Therapeutics(PRWeb November 23, 2015)Read the full story at http://www.prweb.com/releases/2015/11/prweb13096031.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 23, 2015 Category: Pharmaceuticals Source Type: news
Birds that eat at feeders more likely to get sick, spread disease
(Virginia Tech) The authors monitored the social and foraging behaviors of wild flocks of house finches, a common backyard songbird, and the spread of a naturally-occurring bird disease called Mycoplasmal conjunctivitis, which is similar to 'pink eye' in humans but cannot be contracted by humans. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 17, 2015 Category: Infectious Diseases Source Type: news
Birds that eat at feeders are more likely to get sick, spread disease
The authors monitored the social and foraging behaviors of wild flocks of house finches, a common backyard songbird, and the spread of a naturally-occurring bird disease called Mycoplasmal conjunctivitis, which is similar to "pink eye" in humans but cannot be contracted by humans. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 16, 2015 Category: Science Source Type: news
Ocular Therapeutix slides as Q2 beats rev, misses earnings
Ocular Therapeutix (NSDQ:OCUL) announced its 2nd quarter earnings on Monday, beating expectations on revenue but missing on earnings.
Ocular Therapeutics reported losses of $9.6 million, or 45¢ per share, on sales of $459,000 for the 3 months ended June 30. That amounts to a 62% increase in losses on sales growth of 373% compared with the same period last year.
While revenue beat analysts expectations by around $50,000, losses per share missed the mark by 4¢. The company did manage to decrease its loss per share by a whopping 78.6% since last year.
The news has sent shares down, dropping roughly 15% since the announcemen...
Source: Mass Device - August 12, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Optical/Ophthalmic Ocular Therapeutix Inc. Source Type: news
Shire Acquires Foresight Biotherapeutics for $300M
Shire acquires the rights to FST-100, a therapy in late-stage development for the treatment of infectious conjunctivitis, a/k/a pink eye (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 5, 2015 Category: Pharmaceuticals Source Type: news
What Are Common Drug Eruptions in Children?
Discussion
Drug reactions unfortunately are common in children and adults. These reactions have different but often overlapping appearances. Viral exanthams also often cloud the picture as these rashes can be because of the drug, the virus or both.
Patients with urticaria multiforme present with an acute rash that appears as urticaria plaques that have a hemorrhagic or dusky discoloration. It occurs 1-3 days after viral symptoms (including cough, rhinorrhea, diarrhea) and may also present with fever.
Morbilliform drug eruptions one of the most common drug reactions in children and usually occur 7-14 days after the onset ...
Source: PediatricEducation.org - July 27, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
